17 Results for "

CNV

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "CNV" in MCE Product Catalog:

7
7 Publications Verification
Referencia número: HY-B1395
No. CAS: 826-39-1
Áreas de investigación:  

Cardiovascular Disease Neurological Disease

Mecamylamine hydrochloride is an orally active, nonselective, noncompetitive nAChR antagonist. Mecamylamine hydrochloride is also a ganglionic blocker. Mecamylamine hydrochloride can across the blood-brain barrier. Mecamylamine hydrochloride can be used in the research of neuropsychiatric disorders, hypertension, antidepressant area .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-118530
No. CAS: 65002-17-7
Pureza:  98.87%
Synonyms: SA96; Thiobutarit
Target:  

VEGFR

Áreas de investigación:  

Cardiovascular Disease Inflammation/Immunology

Bucillamine (SA96) is an orally active and potent sulfhydryl donor and antioxidant. Bucillamine is also an antirheumatic agent with antiangiogenic properties. Bucillamine can protect against Ischemia/reperfusion (I/R) injury in high-risk organ transplants. Bucillamine inhibits the production of VEGF. Bucillamine can be used for the research of choroidal neovascularization (CNV) and rheumatoid arthritis (RA) .
loading...
    loading...
Referencia número: HY-12796
No. CAS: 934240-30-9
Pureza:  99.85%
Synonyms: Vixotrigine; GSK-1014802; CNV1014802
Target:  

Sodium Channel

Áreas de investigación:  

Neurological Disease

Raxatrigine (GSK-1014802) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.
loading...
    loading...
Referencia número: HY-12796A
No. CAS: 934240-31-0
Pureza:  98.94%
Synonyms: Vixotrigine hydrochloride; GSK-1014802 hydrochloride; CNV1014802 hydrochloride
Target:  

Sodium Channel

Áreas de investigación:  

Neurological Disease

Raxatrigine hydrochloride (GSK-1014802 hydrochloride) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.
loading...
    loading...
Referencia número: HY-153484A
No. CAS: 849758-52-7
Áreas de investigación:  

Others

Bevasiranib sodium is a siRNA designed to silence the genes that produce vascular endothelial growth factor (VEGF). It is widely accepted that vascular endothelial growth factor (VEGF) is a key component in the pathogenesis of choroidal neo-vascularization (CNV), which is a precursor to wet age-related macular degeneration (wet AMD).
loading...
    loading...
Referencia número: HY-132126
No. CAS: 848057-98-7
Pureza:  99.87%
Target:  

SRPK

Áreas de investigación:  

Others

SPHINX is a selective SRPK1 inhibitor with an IC50 value of 0.58 μM. SPHINX effectively reduces Choroidal Neovascularization (CNV) in vivo. SPHINX can be used for the research of (age-related macular degenaration) AMD .
loading...
    loading...
Referencia número: HY-101990
No. CAS: 1031206-36-6
Pureza:  99.81%
Target:  

VEGFR

Áreas de investigación:  

Others

IMS2186 is an anti-choroidal neovascularization (CNV) agent that inhibits angiogenesis upstream of VEGF. IMS2186 can arrest cancer cell cycle in G2/M phase, thus exerting anti-proliferation and anti-angiogenesis effects. IMS2186 has no intraocular toxicity and reduces the amount of eye leakage and diseased cells .
loading...
    loading...
Referencia número: HY-145604
No. CAS: 1433361-02-4
Pureza:  98.37%
Synonyms: RG7774
Vicasinabin (RG7774) is an orally active, selective, and full CB2R agonist, with EC50 values of 2.81 nM and 2.60 nM for human CB2R and mouse CB2R, respectively. Vicasinabin inhibits inflammation, reduces leukocyte adhesion and decreases vascular permeability by selectively activating CB2R. Vicasinabin can be used in the researches for diabetic retinopathy, uveitis and laser-induced choroidal neovascularization .
loading...
    loading...
Referencia número: HY-B1395A
No. CAS: 60-40-2
Áreas de investigación:  

Cardiovascular Disease Neurological Disease

Mecamylamine is an orally active, nonselective, noncompetitive nAChR antagonist. Mecamylamine is also a ganglionic blocker. Mecamylamine can across the blood-brain barrier. Mecamylamine can be used in the research of neuropsychiatric disorders, hypertension, antidepressant area .
loading...
    loading...
Referencia número: HY-153484
No. CAS: 959961-96-7
Áreas de investigación:  

Others

Bevasiranib is a siRNA designed to silence the genes that produce vascular endothelial growth factor (VEGF). It is widely accepted that vascular endothelial growth factor (VEGF) is a key component in the pathogenesis of choroidal neo-vascularization (CNV), which is a precursor to wet age-related macular degeneration (wet AMD).
loading...
    loading...
Referencia número: HY-P10797
TAT-N24 is a cell-permeable TAT peptide as a p55PIK signaling inhibitor. TAT-N24 is effective for corneal neovascularization (CNV) and ocular inflammation by inhibiting the HIF-1α/NF-κB signaling pathway in corneal suture (CS). TAT-N24 also inhibits corneal neovascularization .
loading...
    loading...
Referencia número: HY-175556
Target:  

Dopamine Receptor

Áreas de investigación:  

Neurological Disease

CNV-dopamine is a photoreleasable D2 receptor-selective agonist. CNV-dopamine activates D2 receptors and induces G protein-coupled inwardly rectifying potassium (GIRK) currents. CNV-dopamine is promising for research of disorders like Parkinson’s disease and addiction .
loading...
    loading...
Referencia número: HY-118530R
No. CAS: 65002-17-7
Synonyms: SA96 (Standard); Thiobutarit (Standard)
Áreas de investigación:  

Cardiovascular Disease Inflammation/Immunology

Bucillamine (Standard) is the analytical standard of Bucillamine. This product is intended for research and analytical applications. Bucillamine (SA96) is an orally active and potent sulfhydryl donor and antioxidant. Bucillamine is also an antirheumatic agent with antiangiogenic properties. Bucillamine can protect against Ischemia/reperfusion (I/R) injury in high-risk organ transplants. Bucillamine inhibits the production of VEGF. Bucillamine can be used for the research of choroidal neovascularization (CNV) and rheumatoid arthritis (RA) .
loading...
    loading...
Referencia número: HY-P991310
No. CAS: 1253114-37-2
Synonyms: LT3015; LT-3000

Target:  

LPL Receptor

Áreas de investigación:  

Neurological Disease Cancer

Lpathomab (LT3015; LT-3000) is a human IgG1 monoclonal antibody (mAb) targeting LPA. Lpathomab reduces the release of IL-8 and IL-6 cytokines in SKOV3 cells and blocks LPA-triggered tumor cell migration. Lpathomab reduces neovascularization in Matrigel plug and CNV models. Lpathomab inhibits brain injury in the CCI mouse model. Lpathomab can be used in the study of brain injury, ovarian cancer, diabetic neuropathy, and spinal cord injury. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Referencia número: HY-B1395R
No. CAS: 826-39-1
Mecamylamine (hydrochloride) (Standard) is the analytical standard of Mecamylamine (hydrochloride). This product is intended for research and analytical applications. Mecamylamine hydrochloride is an orally active, nonselective, noncompetitive nAChR antagonist. Mecamylamine hydrochloride is also a ganglionic blocker. Mecamylamine hydrochloride can across the blood-brain barrier. Mecamylamine hydrochloride can be used in the research of neuropsychiatric disorders, hypertension, antidepressant area .
loading...
    loading...
Referencia número: HY-176993
No. CAS: 1995864-97-5
Target:  

Caspase Drug Derivative

Áreas de investigación:  

Cardiovascular Disease Neurological Disease

2-Et-AZT is a modified Azidothymidine (HY-17413). 2-Et-AZT inhibits caspase-1 activation. 2-Et-AZT reduces choroidal neovascularization (CNV) volume .
loading...
    loading...
Referencia número: HY-182372
No. CAS: 1638153-78-2
Target:  

Epoxide Hydrolase

Áreas de investigación:  

Neurological Disease

SH-11037 is a potent inhibitor of soluble epoxide hydrolase (sEH) and docks to the substrate binding cleft in the sEH hydrolase domain. SH-11037 dose-dependently suppresses angiogenesis in the choroidal sprouting assay ex vivo and inhibited ocular developmental angiogenesis in zebrafish larvae. SH-11037 reduces choroidal neovascularisation lesion volume in the laser-induced CNV mouse model. SH-11037 synergises with anti-VEGF treatments in vitro and in vivo. SH-11037 induces G2/M phase blockade and retains retinal endothelial cell viability at active concentrations without overt toxicity. SH-11037 can be used for the research of retinal neovascularization and ocular neovascularization .
loading...
    loading...
  • 1